CMDh Report – March 2025 Meeting
The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published the report from the meeting held on 25-26 March 2025.
Among the items reported, the following may be noted:
CMDH POSITIONS FOLLOWING PSUSA PROCEDURES FOR NATIONALLY AUTHORISED PRODUCTS ONLY
The CMDh, having considered the PSURs on the basis of the PRAC recommendations and the PRAC assessment reports, agreed by consensus on the variation of the marketing authorisations of medicinal products containing the following active substances: naphazoline, naphazoline / zinc sulphate.
In addition, the minutes of the CMDh meeting held on 25-26 February 2025 have been published and can be accessed here.
